Market Cap 783.44M
Revenue (ttm) 0.00
Net Income (ttm) -43.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 976,200
Avg Vol 1,103,926
Day's Range N/A - N/A
Shares Out 85.06M
Stochastic %K 72%
Beta 0.80
Analysts Strong Sell
Price Target $44.00

Latest News on AVXL

Playing The Odds Of Anavex Alzheimer's Drug Approval

Jan 12, 2025, 11:21 AM EST - 3 months ago

Playing The Odds Of Anavex Alzheimer's Drug Approval


Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis

Dec 24, 2024, 8:50 AM EST - 4 months ago

Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis


Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call Transcript

Dec 23, 2024, 10:23 AM EST - 4 months ago

Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call Transcript


Anavex Life Sciences Announces Expansion of Leadership Team

May 22, 2024, 7:30 AM EDT - 1 year ago

Anavex Life Sciences Announces Expansion of Leadership Team